Boost For India’s Generic Pharma Majors
Biocon, Dr Reddy’s and Mankind Pharma stress on development and manufacturing of biological drugs, look to cash in on a growing market.
dr reddys
October 2024
June 2024
July 2023
May 2023
July 2022
Dr. Reddy's buys Haleon's NTR biz outside U.S. for £500 mn
Once the deal closes, Dr. Reddy’s will acquire NRT business in all countries outside of the U.S., though operations will transition to it in a phased manner
Dr. Reddy's Q1 profit surges 18% to ₹1,403 cr
The revenue witnessed 29% growth at ₹6,738.4 crore in the Q1 of FY24, against ₹5,215.4 crore YoY, driven by sales in North America, emerging markets and Europe.
Dr. Reddy’s shares plunge over 5% despite nine-fold profit in March quarter
In the January to March period, the company's revenue from operations surged double-digit by 16% year-on-year (YoY) to ₹6,296.8.2 crore, up from ₹5,436.8 crore in the same period last year.
Dr. Reddy’s Labs drops 5% despite 1,257% sequential growth in Q1 profit; here's why
Dr. Reddy's posted a consolidated net profit of ₹1,187.6 crore in Q1FY23, registering a yearly growth of 108.05% and 1,257.25% on a quarterly basis.
